Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes

被引:21
|
作者
Li, Nong [1 ]
Tan, Huiwen [2 ]
Xie, Aixia [1 ]
Li, Cheng [3 ]
Fu, Xuan [1 ]
Xang, Weiting [1 ]
Kirim, Amina [1 ]
Huang, Xuefang [1 ]
机构
[1] Peoples Hosp Karamay, Dept Endocrinol & Metab, Karamay, Xinjiang, Peoples R China
[2] Sichuan Univ, Dept Endocrinol Metab, West China Hosp, Chengdu, Peoples R China
[3] Xinjiang Med Univ, Affiliated Hosp 1, Urumqi, Peoples R China
关键词
Triglyceride glucose-body mass index; Type; 2; diabetes; Non-alcoholic fatty liver disease; METABOLIC SYNDROME; INSULIN-RESISTANCE; STEATOSIS; SEVERITY; PRODUCT; LIMITATIONS; PROGRESSION; DIAGNOSIS; MELLITUS; NAFLD;
D O I
10.1186/s12902-022-00993-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The triglyceride glucose index combined with body mass index is a new index that reflects the degree of insulin resistance. In this cross-sectional study, we aimed to explore the predictive value of the triglyceride glucose-body mass index (TyG-BMI) in relation to the occurrence of non-alcoholic fatty liver disease (NAFLD) in the Chinese population with type 2 diabetes (T2D). Methods We selected 826 patients with T2D who were hospitalized at the Department of Endocrinology and Metabolism of Karamay People's Hospital from September 2016 to October 2018 for this research. The height, weight, fasting blood glucose, serum insulin, and lipid profiles of the subjects were collected. The liver ultrasound showed any degree of echogenic enhancement of liver tissue and the liver appeared brighter than the renal cortex on ultrasound were considered to be NAFLD. The logistic regression analysis was performed to estimate associations between the triglyceride glucose index (TyG), TyG-BMI index, insulin resistance index (HOMA-IR) and the ratio of the triglycerides to high-density lipoprotein-cholesterol with a diagnosis of NAFLD. The receiver operating characteristic curve method was used to analyze its predictive value for NAFLD. Results Results of the logistic regression analysis showed that the odds ratios of NAFLD were 6.535 (3.70-11.53) and 4.868 (2.576-9.200) for the TyG-BMI before and after correction,respectively(P < 0.001). The area under the curve (AUC) for TyG-BMI was 0.727 (0.691-0.764), which was the highest among all the other parameters studied. Conclusion Compared with the TyG index, the TG/HDL-C and HOMA-IR, the TyG-BMI was a more effective predictor of NAFLD in T2D.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Validation of the Fatty Liver Index for identifying non-alcoholic fatty liver disease in a Kenyan population
    Lajeunesse-Trempe, Fannie
    Boit, Michael K.
    Kaduka, Lydia U.
    De Lucia-Rolfe, Emanuella
    Baass, Alexis
    Paquette, Martine
    Piche, Marie-Eve
    Tchernof, Andre
    Christensen, Dirk L.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2023, 28 (10) : 830 - 838
  • [32] Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis
    Huang, Jee-Fu
    Tsai, Pei-Chien
    Yeh, Ming-Lun
    Huang, Chung-Feng
    Huang, Ching-, I
    Hsieh, Meng-Hsuan
    Dai, Chia-Yen
    Yang, Jeng-Fu
    Chen, Shinn-Chern
    Yu, Ming-Lung
    Chuang, Wan-Long
    Chang, Wen-Yu
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 (01) : 89 - 96
  • [33] The predictive value of the hepatorenal index for detection of impaired glucose metabolism in patients with non-alcoholic fatty liver disease
    Petar Avramovski
    Maja Avramovska
    Zorica Nikleski
    Biljana Ilkovska
    Kosta Sotiroski
    Emilija Sikole
    Indian Journal of Gastroenterology, 2020, 39 : 50 - 59
  • [34] Meta-analysis of the effects of sodium glucose cotransporter 2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes
    Sinha, Binayak
    Datta, Debasis
    Ghosal, Samit
    JGH OPEN, 2021, 5 (02): : 219 - 227
  • [35] Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes
    Nobarani, Sohrab
    Alaei-Shahmiri, Fariba
    Aghili, Rokhsareh
    Malek, Mojtaba
    Poustchi, Hossein
    Lahouti, Maryam
    Khamseh, Mohammad E.
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (04) : 1389 - 1398
  • [36] Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index
    Petta, S.
    Di Marco, V.
    Camma, C.
    Butera, G.
    Cabibi, D.
    Craxi, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (12) : 1350 - 1360
  • [37] Association Between the Risk of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease
    Zhao, Pingping
    Yan, Junxin
    Pan, Binjing
    Liu, Jingfang
    Fu, Songbo
    Cheng, Jianguo
    Wang, Liting
    Jing, Gaojing
    Li, Qiong
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2022, 15 : 1141 - 1151
  • [38] Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus
    Ferreira, Vera S. G.
    Pernambuco, Ricardo B.
    Lopes, Edmundo P.
    Morais, Clarice N.
    Rodrigues, Marbiana C.
    Arruda, Maria Juliana
    Moura e Silva, Lidiane
    Vilar, Lucio
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2010, 54 (04) : 362 - 368
  • [39] Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study
    Motta, Benedetta M.
    Grander, Christoph
    Gogele, Martin
    Foco, Luisa
    Vukovic, Vladimir
    Melotti, Roberto
    Fuchsberger, Christian
    De Grandi, Alessandro
    Cantaloni, Chiara
    Picard, Anne
    Mascalzoni, Deborah
    Rossini, Alessandra
    Pattaro, Cristian
    Tilg, Herbert
    Pramstaller, Peter P.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (01)
  • [40] Triglyceride glucose index as a predictor for non-alcoholic fatty liver disease: insights from a longitudinal analysis in non-obese individuals
    Ning, Qi
    Zheng, Keyang
    Yan, Jiafu
    Zhu, Chao
    FRONTIERS IN MEDICINE, 2024, 11